Related Experiment Video
Updated: Aug 13, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Interstitial lung disease in pregnancy
Divya Mecheril Balachandran1, Abhipreet Bhattachariya1, Ananda Datta2
1Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Deoghar, Jharkhand, India.
Obstetric Medicine
|August 12, 2026
Summary
Pregnancy in women with interstitial lung disease (ILD) is high-risk. Early evaluation, risk assessment, and multidisciplinary care are crucial for optimizing outcomes for both mother and child.
Area of Science:
- Pulmonology
- Obstetrics
- Reproductive Medicine
Background:
- Interstitial lung disease (ILD) is a group of chronic lung disorders causing respiratory dysfunction.
- Increased survival and delayed childbearing lead to more pregnancies in women with ILD.
- Limited evidence exists for managing pregnancy in women with ILD.
Purpose of the Study:
- To review current knowledge on diagnostic evaluation, treatment, and obstetric management for ILD in pregnancy.
- To summarize maternal-fetal outcomes in pregnant women with ILD.
- To emphasize the need for optimized care in preconception and pregnancy for women with ILD.
Main Methods:
- This is a review article.
- It synthesizes existing literature on ILD and pregnancy.
- Focuses on diagnostic, therapeutic, and obstetric aspects.
Main Results:
- Pregnancy in women with ILD presents significant risks.
- Requires comprehensive preconception evaluation and risk stratification.
- A multidisciplinary approach is essential for management.
Conclusions:
- Optimizing care for pregnant women with ILD demands a thorough understanding of diagnostic and management strategies.
- Early intervention and collaborative care improve maternal and fetal outcomes.
- Further research is needed to expand the evidence base for ILD pregnancy management.
Related Concept Videos
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...